Mergers & Acquisitions ·
On July 30, 2026, Vireo Growth Inc. entered into four Securities Purchase Agreements to acquire 100% of…
VREOFVireo Growth Inc.
On July 30, 2026, Vireo Growth Inc. entered into four Securities Purchase Agreements to acquire 100% of FarmaceuticalRx LLC, FarmaceuticalRx 2 LLC, Canoe Hill Ohio LLC, and CAOH LLC for an aggregate estimated purchase price of approximately $208 million. The consideration consists solely of approximately 11 million subordinate voting shares issued in three tranches: 50% at closing, 25% at 90 days post-closing, and 25% at 180 days post-closing. Deferred payments are subject to forfeiture mechanisms if acquired entities underperform EBITDA targets through December 31, 2027. The transactions include related party components involving CEO John Mazarakis in the CAOH acquisition. Closing is expected in Q4 2026, pending regulatory approvals. Vireo Growth Inc. operates as a vertically integrated cannabis company and agricultural markets platform.